for the culture method and one for the DNA probe assay. For the urethral specimens from males, the same procedures were followed without cleansing. For routine bacterial cultures, the first swab taken was inoculated onto two solid media, Thayer-Martin agar (Oxoid) and New York City agar (Oxoid), and was examined after 24 h at 37°C (CO2, 5%). Negative cultures were further incubated for up to 72 h. Isolates were identified as N. gonorrhoeae on the basis of growth and colony characteristics, Gram stain morphotype, and oxidase and catalase reactions and were confirmed with the Gen-Probe Accuprobe N. gonorrhoeae culture identification test (Gen-Probe, Inc.) (8). For each set of specimens collected, the Dacron swab used for the DNA probe assay was taken last. This last swab was placed in the Gen-Probe transport medium and was assayed the same day. A total of 1,750 specimens were collected from the urethra (n = 1,076), the cervix (n = 491), the pharynx (n = 137), and the rectum (n = 46). DNA probe. The Gen-Probe PACE 2 Chlamydia trachomatis-N. gonorrhoeae Rapid Diagnostic System (GP) was used in this study. The PACE 2 system uses a singlestranded DNA probe, labeled with an acridinium ester that is complementary to the rRNA of the target organism (10, 11). All specimens were placed in the GP transport system and delivered to the laboratory and were assayed the same day. During transport, the rRNA was released from the organisms in the transport medium. A portion of the specimen transport medium was added to the DNA probe specific for either C. trachomatis or N. gonorrhoeae to form a stable DNA-RNA hybrid. The remaining labeled, nonhybridized probe was separated from the hybridized DNA probe by using magnetic particles in combination with a hydrolysis reagent (selection reagent). The selectivity of the selection reagent destroyed the chemiluminescent label of nonhybridized probe. The hybrids formed were not affected by this selection reagent and therefore retained their chemiluminescent properties. The adsorbed hybrids bound to the magnetic particles were separated by using a Gen-Probe magnetic
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To determine the performance of the Gen-Probe assay in testing whether patients were cured, we collected specimens from 30 previously probe-positive patients after treatment for their gonorrheal (9 patients) or chlamydial (21 patients) infections. A total of 14 test specimens (seven urethral, six cervical, and one pharyngeal), which were collected from nine (six female and three male) patients diagnosed with gonorrhea, turned out to be negative (mean RLU ratio = 0.2). A total of 21 patients (16 females and 5 males), who originally tested positive for C. trachomatis with the probe assay, were all negative (mean RLU ratio = 0.1) with the probe assay after treatment (19 urethral and 11 cervical specimens).
DISCUSSION
Infection by N. gonorrhoeae remains an important sexually transmitted disease in sexually active adults. Culture on selective media is currently considered the gold standard. Successful culture requires organism viability and timely transport under stringent conditions to the laboratory for processing. Even under these conditions, the sensitivity is reported to be only 85 to 95% (13) . DNA hybridization technology provides an alternative identification method that offers rapid (2-h) results, as well as ease of specimen storage and transportation (9) . In this study, we compared a GenProbe DNA probe assay (GP) with culture for the detection of N. gonorrhoeae in a population of patients visiting the outpatient clinic of the Sexually Transmitted Diseases Department of the Westeinde Hospital. The study population had infection prevalence rates of 14.9 and 7.7% for men and women, respectively. The overall positive rate was 8.7%. Sensitivity of the DNA probe assay for the total population was 97.1%. Specificity of the assay for this group of patients was 99.1%. The predictive positive and negative values were 90.6 and 99.8%, respectively. These are comparable with the values previously reported by Panke et al. (10) . The relatively high prevalence rate of our patient population (8.7%) affected the sensitivity to a lesser extent than reported in the study by Panke et al.
Of the 1,750 total specimens tested, there were 14 false positives with the probe assay. A total of 12 of the samples had sample RLU/cutoff RLU ratios that were higher than 2.0, strongly suggesting true gonorrheal infections. Five samples of the urethral discharges of six male patients were stained with methylene blue. Diplococci were visible in the stained discharges from all five of the patients tested. All 13 patients exhibited one or more characteristics that put them at high risk for sexually transmitted diseases. These included previous gonorrheal infections, promiscuity, and/or engaging in prostitution. Two of the patients were at high risk for sexually transmitted diseases even though they were asymptomatic for gonorrheal infections. The probe assay sample RLU/cutoff RLU ratios for their specimens were 1.3 and 1.4 (patients no. 8 and 12, respectively) ( Table 4 ). In the case of patient no. 12, we could not find further evidence for gonococcal disease; in patient no. 8, the urethral specimen RLU ratio was 41.1 and could be seen as positive. Technical problems, including inoculation of specimens onto cold media (in four cases, it appeared that the nurse had taken the solid media out of the refrigerator minutes before inoculation) and overgrowth by other bacteria, may have contributed to apparent probe false positives. Taking everything into consideration, the additional evidence presented for these 14 specimens suggests that they may be culture false negatives and not probe false positives. These data strongly suggest that the DNA probe assay may be more sensitive than culture for detecting gonorrheal infection. The four samples yielding a positive result in culture and a negative result in the DNA probe assay could be explained by swab-to-swab variability. Because the DNA probe assay swab was taken consistently as the last swab, adverse patient reactions may have resulted in inadequate probe samples.
In the study by Panke et al. (10) , 22 of 3,048 specimens tested in the Gen-Probe assay had sample RLU/cutoff RLU ratios between 0.7 and <2.0. On repeated testing of the 22 specimens, 12 were negative for N. gonorrhoeae and had ratios between 0.7 and <1.0, whereas 10 were positive and had ratios between 1.0 and <2.0. Similarly, in our study, we found 11 samples with ratios between 0.7 and <2.0. Of these, five samples had probe ratios between 0.7 and <1.0 and were negative in culture and probe assay, whereas six samples had probe ratios equal to or higher than 1.0 and less than 2.0 and were positive by culture and/or probe assay. These samples represented 0.4% of all negative tests and 3.9% of all positive tests. All 11 samples were repeatedly tested in our study. We feel that this region around the cutoff should be considered suspect and that new patient samples should be obtained.
No study evaluating the diagnostic value of the GP for specimens from nongenital sites has been published. Nongenital samples were taken from the pharynges (n = 137) and the rectums (n = 46) of 183 patients. In this study, we found eight patients (Table 3) One disadvantage of the DNA probe test is its inability to provide information on j-lactamase production by N. gonorrhoeae. In our region, with an N. gonorrhoeae-positive population with 1-lactamase production of about 50%, treatment with ceftriaxone is a recommended guideline. Because of the earlier findings from surveillance of 1-lactamaseproducing strains and of the emergence of resistance to (for instance) ceftriaxone, epidemiological tracking of antibiotic resistance may be important in the future. Patient samples collected during certain periods should be tested in DNA probe assay and culture.
The advantage of using this DNA probe technique is that simultaneous testing for C. trachomatis of the same specimen is possible. We tested 1,119 of the patients in this study for the presence of C trachomatis. We detected 101 probepositive Chlamydia samples in specimens collected from 87 patients (data not shown). A total of 13 of the Chlamydiapositive patients had concomitant gonorrheal infections. On the basis of data from an earlier evaluation in our laboratory (unpublished data) and of data published by Kluytmans et al. (5) , the Gen-Probe PACE 2 assay to detect C. trachomatis has been fully accepted in our laboratory setting.
In conclusion, the DNA probe test is useful as a suitable screening and diagnostic test for gonorrheal infection in men and women. An advantage of using this DNA probe technique is the fact that the patient specimen can be tested simultaneously for C. trachomatis. The DNA probe assay might also be suitable to use for specimens from nongenital sites. By using rRNA as a control marker after treatment, it may be possible to use the Gen-Probe assay for testing whether patients have been cured. Because the numbers of patients tested were low, further studies are required to determine whether the preceding two statements will hold true.
